Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Medical Devices (Auckland, N.Z.)|August 24, 2012
Everolimus-eluting stents: update on current clinical studiesDominic J Allocco, Anita A Joshi, Keith D DawkinsJournal of Interventional Cardiology|September 20, 2012
Racial differences in long-term outcomes after percutaneous coronary intervention with paclitaxel-eluting coronary stentsWayne B Batchelor, Stephen G Ellis, John A Ormiston, et al.JACC. Cardiovascular Interventions|January 15, 2011
Influence of sex on long-term outcomes after percutaneous coronary intervention with the paclitaxel-eluting coronary stent: results of the "TAXUS Woman" analysisGhada W Mikhail, Robert T Gerber, David A Cox, et al.Circulation. Cardiovascular Interventions|December 25, 2009
Long-term paclitaxel-eluting stent outcomes in elderly patientsDaniel E Forman, David A Cox, Stephen G Ellis, et al.Journal of the American College of Cardiology|February 21, 2012
Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stentIan T Meredith, Stefan Verheye, Christophe L Dubois, et al.Lancet (London, England)|November 15, 2020
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trialSebastian Grosicki, Maryana Simonova, Ivan Spicka, et al.Pageof 1